Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT Study)

Peter MacPherson, Emily L Webb, David G Lalloo, Marriott Nliwasa, Hendramoorthy Maheswaran, Elizabeth Joekes, Dama Phiri, Bertie Squire, Madhukar Pai, Elizabeth L Corbett, Peter MacPherson, Emily L Webb, David G Lalloo, Marriott Nliwasa, Hendramoorthy Maheswaran, Elizabeth Joekes, Dama Phiri, Bertie Squire, Madhukar Pai, Elizabeth L Corbett

Abstract

Background: Adults seeking diagnosis and treatment for tuberculosis (TB) and HIV in low-resource settings face considerable barriers and have high pre-treatment mortality. Efforts to improve access to prompt TB treatment have been hampered by limitations in TB diagnostics, with considerable uncertainty about how available and new tests can best be implemented. Design and methods: The PROSPECT Study is an open, three-arm pragmatic randomised study that will investigate the effectiveness and cost-effectiveness of optimised HIV and TB diagnosis and linkage to care interventions in reducing time to TB diagnosis and prevalence of undiagnosed TB and HIV in primary care in Blantyre, Malawi. Participants (≥ 18 years) attending a primary care clinic with TB symptoms (cough of any duration) will be randomly allocated to one of three groups: (i) standard of care; (ii) optimised HIV diagnosis and linkage; or (iii) optimised HIV and TB diagnosis and linkage. We will test two hypotheses: firstly, whether prompt linkage to HIV care should be prioritised for adults with TB symptoms; and secondly, whether an optimised TB triage testing algorithm comprised of digital chest x-ray evaluated by computer-aided diagnosis software and sputum GeneXpert MTB/Rif can outperform clinician-directed TB screening. The primary trial outcome will be time to TB treatment initiation by day 56, and secondary outcomes will include prevalence of undiagnosed TB and HIV, mortality, quality of life, and cost-effectiveness. Conclusions: The PROSPECT Study will provide urgently-needed evidence under "real-life" conditions to inform clinicians and policy makers on how best to improve TB/HIV diagnosis and treatment in Africa. Clinical trial registration: NCT03519425 (08/05/2018).

Keywords: HIV; Tuberculosis; diagnostics; public health; randomised controlled trials; screening; sub-Saharan Africa; treatment.

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.. PROSPECT Trial Design.
Figure 1.. PROSPECT Trial Design.
WHO: World Health Organization, TB: tuberculosis, HIV: Human immunodeficiency virus, +ve: positive, -ve: negative, ART: antiretroviral therapy, Rx: treatment, +/- : with, or without.

References

    1. World Health Organization: Global tuberculosis report 2017. Geneva,2017.
    1. Murray CJ, Ortblad KF, Guinovart C, et al. : Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–70. 10.1016/S0140-6736(14)60844-8
    1. Corbett EL, Watt CJ, Walker N, et al. : The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009–21. 10.1001/archinte.163.9.1009
    1. World Health Organization: END TB Strategy.Geneva,2016.
    1. Khan MS, Fletcher H, London School of Hygiene and Tropical Medicine TB Centre Steering Committee, et al.: Investments in tuberculosis research - what are the gaps? BMC Med. 2016;14(1):123. 10.1186/s12916-016-0644-0
    1. Harries AD, Lawn SD, Getahun H, et al. : HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc. 2012;15(2):17396. 10.7448/IAS.15.2.17396
    1. Gupta RK, Lucas SB, Fielding KL, et al. : Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29(15):1987–2002. 10.1097/QAD.0000000000000802
    1. MacPherson P, Lalloo DG, Choko AT, et al. : Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi. Trop Med Int Health. 2012;17(4):507–17. 10.1111/j.1365-3156.2011.02946.x
    1. Peter JG, Zijenah LS, Chanda D, et al. : Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet. 2016;387(10024):1187–97. 10.1016/S0140-6736(15)01092-2
    1. MacPherson P, Corbett EL, Makombe SD, et al. : Determinants and consequences of failure of linkage to antiretroviral therapy at primary care level in Blantyre, Malawi: a prospective cohort study. PLoS One. 2012;7(9):e44794. 10.1371/journal.pone.0044794
    1. Macpherson P, Dimairo M, Bandason T, et al. : Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis. 2011;15(10):1390–6. 10.5588/ijtld.11.0056
    1. MacPherson P, Houben RM, Glynn JR, et al. : Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis. Bull World Health Organ. 2014;92(2):126–38. 10.2471/BLT.13.124800
    1. World Health Organization: Systematic screening for active tuberculosis: principles and recommendations.Geneva,2013.
    1. Cazabon D, Alsdurf H, Satyanarayana S, et al. : Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade. Int J Infect Dis. 2017;56:111–116. 10.1016/j.ijid.2016.10.016
    1. Chihota VN, Ginindza S, McCarthy K, et al. : Missed Opportunities for TB Investigation in Primary Care Clinics in South Africa: Experience from the XTEND Trial. PLoS One. 2015;10(9):e0138149. 10.1371/journal.pone.0138149
    1. MacPherson P, Choko AT, Webb EL, et al. : Development and validation of a global positioning system-based "map book" system for categorizing cluster residency status of community members living in high-density urban slums in Blantyre, Malawi. Am J Epidemiol. 2013;177(10):1143–7. 10.1093/aje/kws376
    1. Davis JL, Cattamanchi A, Cuevas LE, et al. : Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(2):147–54. 10.1016/S1473-3099(12)70232-3
    1. Steingart KR, Henry M, Ng V, et al. : Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(9):570–81. 10.1016/S1473-3099(06)70578-3
    1. Cruciani M, Scarparo C, Malena M, et al. : Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol. 2004;42(5):2321–5. 10.1128/JCM.42.5.2321-2325.2004
    1. Steingart KR, Schiller I, Horne DJ, et al. : Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014; (1):Cd009593. 10.1002/14651858.CD009593.pub3
    1. Hoog AH, Meme HK, van Deutekom H, et al. : High sensitivity of chest radiograph reading by clinical officers in a tuberculosis prevalence survey. Int J Tuberc Lung Dis. 2011;15(10):1308–14. 10.5588/ijtld.11.0004
    1. World Health Organization: Chest Radiology in Tuberculosis Detection: Summary of recommendation and guidance on programmatic approaches.Geneva,2016.
    1. Pande T, Cohen C, Pai M, et al. : Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review. Int J Tuberc Lung Dis. 2016;20(9):1226–30. 10.5588/ijtld.15.0926
    1. National Tuberculosis Programme Malawi: National Tuberculosis Prevalence Survey.2015.
    1. Choko AT, MacPherson P, Webb EL, et al. : Uptake, Accuracy, Safety, and Linkage into Care over Two Years of Promoting Annual Self-Testing for HIV in Blantyre, Malawi: A Community-Based Prospective Study. PLoS Med. 2015;12(9):e1001873. 10.1371/journal.pmed.1001873
    1. Kumwenda M, Desmond N, Hart G, et al. : Treatment-Seeking for Tuberculosis-Suggestive Symptoms: A Reflection on the Role of Human Agency in the Context of Universal Health Coverage in Malawi. PLoS One. 2016;11(4):e0154103. 10.1371/journal.pone.0154103
    1. Nliwasa M, MacPherson P, Chisala P, et al. : The Sensitivity and Specificity of Loop-Mediated Isothermal Amplification (LAMP) Assay for Tuberculosis Diagnosis in Adults with Chronic Cough in Malawi. PLoS One. 2016;11(5):e0155101. 10.1371/journal.pone.0155101
    1. Auld AF, Fielding KL, Gupta-Wright A, et al. : Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials? Trans R Soc Trop Med Hyg. 2016;110(8):432–44. 10.1093/trstmh/trw056
    1. Speigelhalter D, Abrams K, Myles J: Bayesian approaches to Clinical trials and health-care evaluation.Chichester, England: John Wiley and Sons ltd.;2004. 10.1002/0470092602
    1. Lachin JM: Sample size and power for a logrank test and Cox proportional hazards model with multiple groups and strata, or a quantitative covariate with multiple strata. Stat Med. 2013;32(25):4413–25. 10.1002/sim.5839
    1. Sox HC, Lewis RJ: Pragmatic Trials: Practical Answers to "Real World" Questions. JAMA. 2016;316(11):1205–6. 10.1001/jama.2016.11409
    1. MacPherson P, MacPherson EE, Mwale D, et al. : Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi. J Int AIDS Soc. 2012;15(2):18020. 10.7448/IAS.15.2.18020
    1. Choko AT, Fielding K, Stallard N, et al. : Investigating interventions to increase uptake of HIV testing and linkage into care or prevention for male partners of pregnant women in antenatal clinics in Blantyre, Malawi: study protocol for a cluster randomised trial. Trials. 2017;18(1):349. 10.1186/s13063-017-2093-2
    1. Lai RP, Meintjes G, Wilkinson RJ: HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Semin Immunopathol. 2016;38(2):185–98. 10.1007/s00281-015-0532-2
    1. Theron G, Peter J, Dowdy D, et al. : Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? Lancet Infect Dis. 2014;14(6):527–32. 10.1016/S1473-3099(13)70360-8
    1. Maheswaran H, Petrou S, MacPherson P, et al. : Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi. BMC Med. 2016;14:34. 10.1186/s12916-016-0577-7

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir